64362-41-0

Basic information

• Product Name: ALPHA-[2-(3'-NITROPYRIDINYL)] DIETHYL MALONATE
• Synonyms: ALPHA-[2-(3'-NITROPYRIDINYL)] DIETHYL MALONATE;diethyl 2-(3-nitropyridin-2-yl)Malonate;Propanedioic acid, 2-(3-nitro-2-pyridinyl)-, 1,3-diethyl ester
• CAS NO: 64362-41-0
• Molecular Formula: C₁₂H₁₄N₂O₆
• Molecular Weight: 282.251
• Mol File: 64362-41-0.mol
• Article Data: 22

Chemical Properties

• Boiling Point: 391.8±37.0 °C(Predicted)
• Appearance: /
• Density: 1.297±0.06 g/cm3(Predicted)
• PKA: 8.61±0.46(Predicted)
• CAS DataBase Reference: ALPHA-[2-(3'-NITROPYRIDINYL)] DIETHYL MALONATE(CAS DataBase Reference)
• NIST Chemistry Reference: ALPHA-[2-(3'-NITROPYRIDINYL)] DIETHYL MALONATE(64362-41-0)
• EPA Substance Registry System: ALPHA-[2-(3'-NITROPYRIDINYL)] DIETHYL MALONATE(64362-41-0)

Safety Data

• Hazardous Substances Data: 64362-41-0(Hazardous Substances Data)

Usage

General Description

ALPHA-[2-(3'-nitropyridinyl)] diethyl malonate is an organic compound with the chemical formula C13H15N3O6. It is a nitro-substituted malonate ester that is commonly used in organic synthesis as a building block for various pharmaceuticals and agrochemicals. ALPHA-[2-(3'-NITROPYRIDINYL)] DIETHYL MALONATE is known for its versatile reactivity, which allows it to participate in a wide range of organic reactions, including alkylation, acylation, and esterification. Its nitro group can also be reduced to an amino group, providing opportunities for further diversification of its chemical structure. ALPHA-[2-(3'-nitropyridinyl)] diethyl malonate is a valuable tool for synthetic chemists in the development of new molecules and materials.

Upstream product

• 5470-18-8 2-Chloro-3-nitropyridine 
• 105-53-3 diethyl malonate 
• 996-82-7 sodium diethylmalonate 
• 996-82-7 sodium diethylmalonate 
• 107-83-5 2-Methylpentane 

Downstream Products

• 18699-87-1 2-methyl-3-nitropyridine 
• 87592-14-1 3-ethoxycarbonyl-4-azaindol-2(3H)-one 
• 87592-15-2 3-ethoxycarbonyl-1-hydroxy-4-azaindol-2(3H)-one 
• 154078-83-8 ethyl 2-(3-nitro-pyridin-2-yl)-acetate 
• 272-49-1 1H-pyrrolo[3,2-b]pyridine 
• 65156-92-5 (E)-N,N-dimethyl-2-(3-nitropyridin-2-yl)ethenamine 
• 295327-27-4 ethyl 2-(3-amino-pyridin-2-yl)-acetate 
• 504433-23-2 GW441756 
• 853685-35-5 1H-pyrrolo[3,2-b]pyridine-2-carboxylic acid amide 
• 17288-35-6 1H-pyrrolo[3,2-b]pyridine-2-carboxylic acid 
• 853685-37-7 3-phenylsulfanyl-1H-pyrrolo[3,2-b]pyridine-2-carboxylic acid amide 
• 853685-38-8 3-(3-fluorophenyl)sulfanyl-1H-pyrrolo[3,2-b]pyridine-2-carboxylic acid amide 
• 17288-32-3 1H-pyrrolo[3,2-b]pyridine-2-carboxylic acid ethyl ester 
• 1344663-68-8 2-methyl-3-nitro-6-phenylpyridine-1-oxide 

Relevant articles and documents

TRIAZINE DERIVATIVE HAVING EGFR INHIBITORY ACTIVITY, PREPARATION METHOD THEREFOR AND USE THEREOF

Disclosed are a triazine derivative having EGFR inhibitory activity, a preparation method therefor and use thereof. In particular, disclosed are an EGFR inhibitor having a structure of formula (I), a preparation method therefor, a pharmaceutical composition containing same, use thereof for preparing the EGFR inhibitor, and use thereof in preparing medicaments for treating and/or preventing cancers, tumors or metastatic diseases at least partially related to insertion, deletion or other mutation of EGFR exon 20, and in particular use thereof in preparing medicaments for treating and/or preventing hyperproliferative diseases and diseases inducing cell death disorders. The definition of each substituent of formula (I) is the same as that in the description.

NEW PROPANAMINE DERIVATIVES FOR TREATING PAIN AND PAIN RELATED CONDITIONS

The present invention relates to new compounds of general formula (I) that show dual activity towards α2δ subunit of voltage-gated calcium channels (VGCC), especially the α2δ-1 subunit, and to the noradrenaline transporter (NET). The invention is also rel

SELECTIVE INHIBITORS OF CLINICALLY IMPORTANT MUTANTS OF THE EGFR TYROSINE KINASE

The present invention provides compounds of Formula (I) or a subgeneric structure or species thereof, or a pharmaceutically acceptable salt, ester, solvate, and/or prodrug thereof, and methods and compositions for treating or ameliorating abnormal cell proliferative disorders, such as cancer, wherein A, R2, R3, R10, E1, E2, E3, Y, and Z are as defined herein.